HubSpot Inc vs Sanofi SA — how do they compare? HubSpot Inc trades at $217.27 (market cap $11.84B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 8.9× HubSpot Inc's market cap, and Sanofi SA pays a 5.5% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals.
| HUBS | SNY | |
|---|---|---|
Market Cap | $11.84B | $104.83B |
Sector | Technology | Health |
52-Week High | $560.90 | $52.34 |
52-Week Low | $170.39 | $41.33 |
Enterprise Value | $10.39B | $121.32B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →